Stereotaxis (STXS) Capital Expenditures (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Stereotaxis | 187.40 Mn | 172.78 Mn | 3.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.86% |
| Mar 31, 2025 | 1,050.00% |
| Dec 31, 2024 | -80.00% |
| Sep 30, 2023 | 42.86% |
| Jun 30, 2023 | -97.99% |
| Mar 31, 2023 | -5.42% |
| Dec 31, 2022 | 80.00% |
| Sep 30, 2022 | -68.46% |
| Jun 30, 2022 | -43.67% |
| Mar 31, 2022 | -3.51% |
| Dec 31, 2021 | 2,245.10% |
| Sep 30, 2021 | -56.03% |
| Jun 30, 2021 | 241.18% |
| Dec 31, 2019 | 127.60% |
| Mar 31, 2019 | -0.96% |
| Dec 31, 2018 | -95.00% |
| Sep 30, 2018 | 323.88% |
| Jun 30, 2018 | 369.21% |
| Mar 31, 2018 | 5.21% |
| Dec 31, 2017 | -85.99% |
| Dec 31, 2015 | 1,169.14% |
| Mar 31, 2015 | -31.29% |
| Dec 31, 2014 | 1,073.42% |
| Dec 31, 2012 | -96.51% |
| Sep 30, 2012 | -44.49% |
| Jun 30, 2012 | -62.61% |
| Mar 31, 2012 | 39.76% |
| Dec 31, 2011 | -83.53% |
| Sep 30, 2011 | 26.47% |
| Jun 30, 2011 | -15.13% |
| Mar 31, 2011 | 202.42% |
| Dec 31, 2010 | 94.13% |